Pharmaceutical company Sandoz sued rival Amgen in US court over its rheumatoid arthritis drug Enbrel, accusing it of an illegal scheme to stymie competition from cheaper biosimilar versions of the medication.

Subscribe to The Daily Docket: https://reut.rs/4bYtR5B
Post image

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service